- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05357703
Efficacy of a Home-Use Photobiomodulation Device for the Treatment of Patients With Knee Osteoarthritis (PBM&KOA-02)
Evaluation of the Efficacy of a Home-Use Photobiomodulation Device for the Treatment of Patients With Knee Osteoarthritis: An Open Label, Single-Arm Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Eligible patients with knee osteoarthritis will receive a B-Cure laser device for self-application at home in addition to standard care. Patients will be invited to the clinic for 3 visits: baseline, 1, and 2 months. Evaluations at the visits will include physical examination, knee range of motion, time up&go test, and patient reported outcomes including subjective pain level by visual analogue scale (VAS), functional and quality of life questionnaires.
The study hypothesis is that B-Cure laser treatments, applied, at home, by the patient, can ameliorate KOA related inflammation thereby reducing pain and improving functionality in these patients.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jehad Khazen, MD
- Phone Number: +972545600095
- Email: khazenjehad@gmail.com
Study Locations
-
-
-
Nazareth, Israel
- Recruiting
- Holy Family Hospital
-
Contact:
- Jehad Khazen, MD
- Phone Number: 972545600095
- Email: khazenjehad@gmail.com
-
Contact:
- Maroun Yacoub
- Phone Number: +9720543349738 +9720543349738
- Email: maroun@gd-energies.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnoses of knee osteoarthritis by American College of Rheumatology (ACR)
- Kellgren & Lawrence classification 2-3
- Knee pain on movement 40 to 90 mm Visual Analog Scale
- Knee pain and related functional reduction for the last ≥ 3 months
- Agrees not to use NSAIDs throughout the experiment
Exclusion Criteria:
- Pregnant or nursing, or with the ability to become pregnant and not using an accepted form of birth control
- Other causes of knee-related pain (e.g. hip OA, arterial insufficiency, radiculopathy etc) have been ruled out by physical examinations.
- Knee surgery for KOA
- Intra-articular steroid injection and/or oral steroid treatment within the last six months
- Rheumatoid arthritis
- Active malignancy
- Uncontrolled diabetes mellitus
- Neurological conditions: sciatica, neuropathy, multiple sclerosis
- Other chronic pain conditions that may affect results: Fibromyalgia, back pain, hip pain
- Has any photobiomodulation (low level laser) device at home or has previously used photobiomodulation for knee pain
- Has known dermatological sensitivity to light
Enrolled in any other clinical trial within the last 6 weeks or enrollment in another clinical trial during participation in this trial.
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Standard treatment + Active B-Cure laser
Subjects from Standard treatment + Active B-Cure laser will receive standard care and in addition will self-treat at home with the B-Cure device.
|
The B-Cure laser pro is a portal, non-invasive, photobiomodulation device, that emits light in the near infrared (808nm) over an area of 1X4.5 cm2 with power output of 250mW, and energy dose of 5J/minute.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
level of pain
Time Frame: one month
|
Change from baseline in pain score by VAS
|
one month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in WOMAC score [ time point - 1 month]
Time Frame: one month
|
The WOMAC is a disease-specific tool used for people with hip or knee OA to measure physical function, pain, and stiffness.
It widely used in clinical studies as primary or secondary outcome.
|
one month
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Marwan Hadad, MD, The Holy Family Hospital, Nazareth, Israel
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HFH-256-2022
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Tianjin XinChen-Techfields Pharma Co., LTD.Completed
-
Eun Jung KimMinistry of Health & Welfare, Korea; Semyung UniversityUnknownOsteoarthritis KneeKorea, Republic of
-
Novartis PharmaceuticalsRecruitingSymptomatic Knee OsteoarthritisUnited States, Spain, Hungary, Argentina, Germany, Slovakia, Czechia, Belgium, Romania
-
University of BathUniversity of Oxford; 3D Metal Printing Ltd; Versus ArthritisRecruitingMedial Knee OsteoarthritisUnited Kingdom
Clinical Trials on Standard treatment + Active B-Cure laser
-
Hillel Yaffe Medical CenterUnknown
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Scarborough Rouge HospitalRecruitingDiabetic Foot UlcerCanada
-
Erika Carmel ltdNot yet recruitingDiabetic Foot UlcerIsrael
-
Hadassah Medical OrganizationUnknownDiabetic Foot UlcerIsrael
-
Erika Carmel ltdNot yet recruiting
-
Erika Carmel ltdRecruitingHead and Neck Cancer | Mucositis | Radiotherapy Side EffectIsrael
-
William Beaumont HospitalsWithdrawnUrinary Incontinence | Stress Urinary IncontinenceUnited States
-
University of Texas Southwestern Medical CenterTerminated
-
Leiden University Medical CenterRecruitingTwin Anemia Polycythemia SequenceUnited States, Italy, Netherlands, Spain, Sweden